We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$548M
AUM Growth
+$35.5M
Cap. Flow
-$7.48M
Cap. Flow %
-1.37%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$10.1M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 28.59%
2 Consumer Staples 20.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOR
1
DELISTED
QUESTCOR PHARMA INC
QCOR
$189M 34.55%
2,046,660
-205,000
-9% -$17.6M
STAA icon
2
STAAR Surgical
STAA
$1.21B
$116M 21.12%
6,887,095
– –
MNST icon
3
Monster Beverage
MNST
$94.3B
$114M 20.73%
9,594,816
– –
MNST icon
4
PUT
Monster Beverage
MNST
$94.3B
$71M 12.96%
6,000,000
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$40.9M 7.47%
16,630,344
+4,460,444
+37% +$10.1M
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$17.4M 3.17%
817,029
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Broadwood Capital held 6 positions worth $548M, up 6.9% from $512M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q2 2014, an estimated $10.1M increase.
  • Broadwood Capital's biggest Q2 2014 reduction was QUESTCOR PHARMA INC, cutting an estimated $17.6M.
  • Broadwood Capital's ten largest holdings make up 100% of its $548M portfolio in Q2 2014.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2014.
  • Broadwood Capital's portfolio value rose 6.9% quarter-over-quarter to $548M.

Based on Broadwood Capital's 13F filing for Q2 2014, filed 14 Aug 2014.